Christine Preibisch1,2, Mathias Lukas3, Anne Kathrin Kluge1, Claus Zimmer1, Stefan Förster3,4, and Thomas Pyka3
1Dept. of Neuroradiology, Technische Universität München, Munich, Germany, 2Clinic for Neurology, Technische Universität München, Munich, Germany, 3Clinic for Nuclear Medicine, Technische Universität München, Munich, Germany, 4Clinic for Nuclear Medicine, Klinikum Bayreuth, Bayreuth, Germany
Synopsis
Hypoxia plays an
important role in prognosis and therapy response of cancer. This study explores the characteristics of
multi-parametric measurements of relative oxygen extraction fraction (rOEF) in
a sample of 36 mostly high grade glioma patients. This study confirms previous results in human glioma
where rOEF values were found to increase with tumor grade but does not find a
similar increase of a supposedly hypoxic tumor area with tumor grade. According
to present results, high rOEF values, supposedly corresponding to a high oxygen
extraction, prevail in edematous tissue with low rCBV. Whether this translates
into tissue hypoxia, needs further investigation.
Purpose
Hypoxia is assumed to play an important role in the prognosis
and therapy response of glioblastoma.1 Therefore, a robust method for imaging of
hypoxia is urgently wanted. In recent years, MRI methods based on the blood
oxygenation level dependent (BOLD) effect have been thoroughly investigated 2,3
and a multi-parametric method for the measurement of an apparent relative
oxygen extraction fraction (rOEF) has been successfully applied in glioma patients.4
However, a number of confounding influences like susceptibility artifacts,
orientation effects within white matter and systematic errors due to model
inadequacies impede straightforward application.5 Since direct
validation with hypoxia-related PET tracers like 18F-FMISO 6
is difficult,7 this study aims to shed some light on the potential significance
of BOLD based oxygenation measures in glioma, by exploring the characteristics
of multi-parametric rOEF measurements in a sample of 36 mostly high grade
glioma patients from a multimodal MR/PET study.
Methods
45 patients (57.8±16.8, 26 men) with suspected
glioma (30 °IV (GBM), 5 °III, 7 °II, 3 other) underwent a simultaneous MRI and
dynamic
18F-FET-PET examination on a clinical 3 T Biograph mMR
scanner (Siemens Medical Solutions). The advanced clinical MRI protocol comprised
R2' mapping (voxel size 2x2x3 mm
3, matrix 128x128, 30 slices) by
separate acquisition of a multi-gradient echo (12 echoes, TE1 = 5 ms,
TE = 5 ms, TR = 1950 ms, α = 30°, rapid flyback, acq.
time 4:08min) and a multi-echo TSE sequence (8 echoes, TE
1 = 16 ms,
TE = 16 ms, TR = 4040 ms, acq. time 5:04
min). Relative cerebral blood volume (rCBV) was obtained by dynamic
susceptibility contrast (DSC) imaging (single-shot GE EPI: TR = 1500 ms, TE = 30
ms, α = 90°, 60-80 dynamics) during a bolus injection of 15 ml Gd-DTPA (prebolus
of 7.5 ml).
8 Data processing used SPM8 (www.fil.ion.ucl.ac.uk/spm)
and custom programs in Matlab (MathWorks). T2* evaluation included correction for
motion and magnetic background gradients and T2 fitting was restricted to even
echoes.
5 $$$rOEF=\frac{R2'}{c\cdot rCBV}$$$ was
calculated from $$$R2'=\frac{1}{T2^*}-\frac{1}{T2}$$$ and rCBV using $$$c=4/3\cdot π\cdot γ\cdot ∆χ\cdot B_0 = $$$ 317 Hz at 3T.
5 Volumes of interest (VOI) were defined with Vinci (http://www.nf.mpg.de/vinci3)
as follows: Control - unaffected contralateral tissue; Edema - very bright
FLAIR signal; T2T - FLAIR-visible
solid appearing tumor; CET - tumor
tissue with T1 contrast enhancement; rOEF > μ+σ - tumor
areas with high rOEF values (larger than sum of mean (µ) and
standard deviation (σ) of rOEF in the control region). Special care was
taken to exclude artifacts (areas with necrosis, bleeding, iron deposition, macroscopic
susceptibility perturbation, Fig. 1).
Results
rOEF maps with
diagnostic quality could be obtained in 36 patients (26 GBM, 5 °III, 5 °II).
Fig.1 shows images from a GBM patient with a large necrosis and edema,
illustrating VOI selection and artifact exclusion. Fig. 2 depicts the relative volumes
of the evaluated VOIs (2a) together with the patient averages of rOEF (2b),
rCBV (2c) and R2' (2d) obtained within these VOIs for glioma of different grade.
Compared to Edema and solid appearing tumor with FLAIR signal alterations
(T2T), areas with contrast enhancement (CET) and supra-threshold rOEF values (rOEF
> μ+σ)
are relatively small. This is also due to the fact necrotic and hemorrhagic areas were excluded. While the
lowest rOEF values occur within CET, within each VOI, rOEF shows a clear trend
to be higher in GBM than °III and °II glioma (Fig. 2b). Comparison with rCBV (Fig.
2c) and R2' (Fig. 2d) behavior suggests that the difference within VOIs is
mainly influenced by R2' while between VOIs rCBV appears to be the dominating
factor. While rCBV appears to be distinctly different between VOIs, especially
between Edema and CET, but similar across tumor grades, R2' clearly varies with
tumor grade especially within edema.
Discussion and Conclusion
Despite the painstaking exclusion of any area with artificial,
i.e. non-oxygenation related, R2' enhancement, these results clearly confirm
previous findings in human glioma where rOEF values were found to increase with
tumor grade within similar VOIs.
5 However, unlike in this previous
study,
5 we did not find a clear increase of the supposedly hypoxic
tumor area, i.e. the area with supra-threshold rOEF values, with tumor grade. In
our opinion, this can mostly be explained by the exclusion of any central necrosis
which represents a large hypoxic area in most high grade glioma. According to
these results, high rOEF values, supposedly corresponding to a high oxygen
extraction, prevail in edematous areas with low rCBV. Whether this also
translates into tissue hypoxia, clearly needs further investigation.
Acknowledgements
This work was
supported by the Deutsche Forschungsgemeinschaft (PR 1039/4-1).
References
1.
Heddleston
JM, Li Z, McLendon RE, et al. The hypoxic microenvironment maintains
glioblastoma stem cells and promotes reprogramming towards a cancer stem cell
phenotype. Cell Cycle. 2009; 8(20):3274-84.
2.
Christen
T, Bolar DS, Zaharchuk G. Imaging brain oxygenation with MRI using blood
oxygenation approaches: methods, validation, and clinical applications. AJNR Am
J Neuroradiol. 2013; 34(6):1113-23.
3.
Yablonskiy
DA, Sukstanskii AL, He X. Blood oxygenation level-dependent (BOLD)-based
techniques for the quantification of brain hemodynamic and metabolic properties
- theoretical models and experimental approaches. NMR Biomed. 2013;
26(8):963-86.
4.
Tóth
V, Förschler A, Hirsch NM, et al. MR-based hypoxia measures in human
glioma. J Neurooncol. 2013;
115(2):197-207.
5.
Hirsch
NM, Toth V, Förschler A, et al. Technical considerations on the validity of
blood oxygenation level-dependent-based MR assessment of vascular
deoxygenation. NMR Biomed. 2014; 27(7):853-62.
6.
Rasey
JS, Koh WJ, Evans ML, et al. Quantifying regional hypoxia in human tumors with
positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of
37 patients. Int J Radiat Oncol Biol Phys. 1996; 36(2):417-28.
7.
Preibisch
C, Lukas M, Kluge A,
et al. Multimodal MR/PET Imaging for Characterization of Hypoxia in
Human Glioblastoma Proc. Intl. Soc. Mag. Reson. Med. 2015; 23:480
8.
Kluge
A, Lukas M, Tóth V,
et al. Comparison of Different
Leakage-Correction Methods for DSC-Based CBV Measurement in Human Gliomas.
Proc. Intl. Soc. Mag. Reson. Med. 2015; 23:3059.